An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044

NCT02319642 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
347
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma SA

Collaborators